Dr. Vivek Venkat Consultant Uro-oncologist and Robotic Urologist

  • Urology Surgery
  • About Dr. Vivek Venkat

    Urology Surgery

    Brief Profile
    • Dr. Venkat is a consultant Uro-Oncologist and Robotic Urologist who completed 3-years (2-year fellowship and 1-year as faculty) at the University of Miami,USA. He is also a visiting Assistant Professor to Miami and has an experience of over 600 robotic surgeries.
    • Speciality Interest:
    • Prostate – cancer, BPH
    • Kidney masses
    • Bladder cancer
    • Testicular cancer
    • Adrenal masses
    • Penile cancer
    • Renal transplant
    • Fellow in Urologic Oncology and Robotic Surgery, University of Miami Miller School of Medicine, Miami, USA – 2017
    • M.Ch. Urology, Christian Medical College, Vellore – 2013
    • M.S. General Surgery, Seth G.S. Medical College and K.E.M. Hospitals, Mumbai – 2009
    • M.B.B.S., B.J. Medical College, Pune - 2005
    • Visiting Assistant Professor of Urology, University of Miami Miller School of Medicine, USA
    • Instructor in Urology and Urologic Oncology, University of Miami Miller School of Medicine, Miami, USA
    • Fellow in Urologic Oncology and Robotic Surgery, University of Miami Miller School of Medicine, Miami, USA
    • Assistant Professor in Urology and Renal Transplantation, Christian Medical College, Vellore.
    • Senior Registrar in Urology and Renal Transplantation, Max Superspeciality Hospitals, Mohali.
    • Resident in Urology and Renal Transplantation, Christian Medical College, Vellore
    • Clinical Assistant in Urology, Pune
    • Resident in General Surgery, Seth GS Medical College and KEM Hospitals, Mumbai
    Awards and Achievements
    • Part of the landmark Robotic versus Open Radical Cystectomy trial – the first multicenter phase 3 clinical trial comparing open to robotic surgery for any organ site in the world – published in the prestigious journal The Lancet in June 2018.
    • Dr. Seetharaman Memorial Best Essay prize at the annual conference of the Urological Society of India (USICON) at New Delhi, January 2014 for my essay on “Urovision 2020: The Future of Urology”.
    • Shaliwahan Singh Rawal Gold Medal for the Best Student in Urology by the Department of Urology, CMC, Vellore for exceptional performance throughout the residency and at the final M.Ch. examinations.
    • C.K.P. Menon Best Paper award for the presentation ‘Monopolar versus bipolar trans-urethral resection of bladder tumours (TURBT): A single-centre, parallel arm, randomized controlled trial’ at the annual conference of the Urological Society of India (USICON) at Pune, January 2013.
    • Selected by the Urological Society of India (USI) to attend the annual European Union Residents Education Program (EUREP) at Prague, Aug 31st – Sept 5th, 2012.
    • ‘Exstrophy-epispadias complex – Adult presentation: An audit’ presented in the Best Paper section at the annual conference of the South Zone – Urological Society of India (SZ-USICON) at Mahabalipuram, July 2011.
    • ‘Dental Caries in Thalassemic Children aged 1-12years’ received the Best Poster Award at the Annual Conference of the Research Society of B J Medical College in 2004.
    • Won the Undergraduate Open Quiz at the 31st Annual Conference of the Research Society of B J Medical College in 2004.
    • Won the Inter College Preventive and Social Medicine (PSM) Quiz held at Armed Forces Medical College, Pune on World Health Day 2002.
    • Won the Maharashtra state level PSM quiz in November 2002.
    • Multiple distinctions throughout M.B.B.S examinations.
    • American Urological Association.
    • South East Section of the American Urological Association.
    • Associate Member, Urological Society of India.
    • Associate Member, Association of Southern Urologists.
    Research and Publications

       A) Journal articles
      1: Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
      Parekh, Dipen J et al. The Lancet , Volume 391 , Issue 10139 , 2525 – 2536.
      2: Trends in Utilization of Robotic and Open Partial Nephrectomy for Management of cT1 Renal Masses. Alameddine M, Koru-Sengul T, Moore KJ, Miao F, Sávio LF, Nahar B, Prakash NS, Venkatramani V, Jue JS, Punnen S, Parekh DJ, Ritch CR, Gonzalgo ML. Eur Urol Focus. 2018 Jan 8. pii: S2405-4569(17)30293-6. doi: 10.1016/j.euf.2017.12.006. [Epub ahead of print] PubMed PMID: 29325761.
      3: Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy formuscle-invasive bladder cancer. Ritch CR, Balise R, Prakash NS, Alonzo D, Almengo K, Alameddine M, Venkatramani V, Punnen S, Parekh DJ, Gonzalgo ML.
      BJU Int. 2017 Dec 27. doi: 10.1111/bju.14109. [Epub ahead of print] PubMed PMID: 29281848.
      4: A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry. Venkatramani V, Koru-Sengul T, Miao F, Nahar B, Prakash NS, Swain S, Punnen S, Ritch C, Gonzalgo M, Parekh D. Urol Oncol. 2018 Mar;36(3):90.e9-90.e14. doi: 10.1016/j.urolonc.2017.11.008. Epub 2017 Dec 16. PubMed PMID: 29254672.
      5: Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy. Nahar B, Koru-Sengul T, Miao F, Prakash NS, Venkatramani V, Gauri A, Alonzo D, Alameddine M, Swain S, Punnen S, Ritch C, Parekh DJ, Gonzalgo ML. World J Urol. 2018 Mar;36(3):393-399. doi: 10.1007/s00345-017-2140-3. Epub 2017 Dec 11. PubMed PMID: 29230495.
      6: Reclassification Rates of Patients Eligible for Active Surveillance After the Addition of Magnetic Resonance Imaging-Ultrasound Fusion Biopsy: An Analysis of 7 Widely Used Eligibility Criteria. Nahar B, Katims A, Barboza MP, Soodana Prakash N, Venkatramani V, Kava B, Satyanarayana R, Gonzalgo ML, Ritch CR, Parekh DJ, Punnen S. Urology. 2017 Dec;110:134-139. doi: 10.1016/j.urology.2017.08.016. Epub 2017 Aug 24. PubMed PMID: 28842208.
      7: Current Status of Nephron-Sparing Surgery (NSS) in the Management of Renal Tumours. Venkatramani V, Swain S, Satyanarayana R, Parekh DJ. Indian J Surg Oncol. 2017 Jun;8(2):150-155. doi: 10.1007/s13193-016-0587-0. Epub 2017 Jan 30. Review. PubMed PMID: 28546710; PubMed Central PMCID: PMC5427030.
      8: Imaging for the selection and monitoring of men on active surveillance for prostate cancer. Velasquez MC, Soodana-Prakash N, Venkatramani V, Nahar B, Punnen S. Transl Androl Urol. 2018 Apr;7(2):228-235. doi: 10.21037/tau.2017.08.13. Review. PMID: 29732281
      9: Using microscope for onco-testicular sperm extraction for bilateral testis tumors. Carrasquillo R, Sávio LF, Venkatramani V, Parekh D, Ramasamy R. Fertil Steril. 2018 Apr;109(4):745. doi: 10.1016/j.fertnstert.2018.01.016. PMID: 29653719
      10: Perioperative complications and postoperative outcomes of partial nephrectomy for renal cell carcinoma: Does indication matter? Venkatramani V, Kumar S, Chandrasingh J, Devasia A, Kekre NS. Indian J Urol. 2017 Apr-Jun;33(2):140-143. doi: 10.4103/0970-1591.203420. PubMed PMID: 28469302; PubMed Central PMCID: PMC5396402.
      11: Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. Jue JS, Barboza MP, Prakash NS, Venkatramani V, Sinha VR, Pavan N, Nahar B, Kanabur P, Ahdoot M, Dong Y, Satyanarayana R, Parekh DJ, Punnen S. Urology. 2017 Jul;105:123-128. doi: 10.1016/j.urology.2017.04.015. Epub2017 Apr 18. PubMed PMID: 28431993.
      12: Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial. Venkatramani V, Panda A, Manojkumar R, Kekre NS. J Urol. 2014 Jun;191(6):1703-7. doi: 10.1016/j.juro.2013.12.004. Epub 2013 Dec 11. PubMed PMID: 24333244.
      13: Re: Hussain AA et al. Reoperations following robot-assisted radical cystectomy: A decade of experience: Editorial Comment. Venkatramani V, Parekh DJ. J Urol. 2016 May;195(5):1375. doi: 10.1016/j.juro.2015.10.193. Epub 2016 Feb 4. Review. PubMed PMID: 26851996.
      14: Urovision 2020: The future of urology. Venkatramani V. Indian J Urol. 2015 Apr-Jun;31(2):150-5. doi: 10.4103/0970-1591.152918. PubMed PMID: 25878422; PubMed Central PMCID: PMC4397557.
      15: Bilateral ovarian metastases from ureteric urothelial cancer: Initial case report and distinguishing role of immunohistochemistry. Venkatramani V, Banerji JS, Manojkumar R.
      Can Urol Assoc J. 2015 Jan-Feb;9(1-2):E52-4. doi: 10.5489/cuaj.2374. PubMed PMID: 25624971; PubMed Central PMCID: PMC4301973.
      16: Is thrombocytosis a useful prognostic marker in renal cell carcinoma? Results of a single-center retrospective analysis. Venkatramani V, Panda A, Kekre NS. Indian J Urol. 2015 Jan-Mar;31(1):42-6. doi: 10.4103/0970-1591.145292. PubMed PMID: 25624575; PubMed Central PMCID: PMC4300571.
      17: Exstrophy-epispadias complex presenting in adulthood: a single-center review of presentation, management, and outcomes. Venkatramani V, Chandrasingh J, Devasia A, Kekre NS. Urology. 2014 Nov;84(5):1243-7. doi: 10.1016/j.urology.2014.06.063. Epub 2014 Oct 24. PubMed PMID: 25443942.
      18: Spontaneous perinephric hemorrhage (Wunderlich syndrome) secondary to polyarteritis nodosa: Computed tomography and angiographic findings. Venkatramani V, Banerji JS. Indian J Urol. 2014 Oct;30(4):452-3. doi: 10.4103/0970-1591.139585. PubMed PMID: 25378832; PubMed Central PMCID: PMC4220390.
      19: Incidental detection of retroperitoneal lymphangioleiomyomatosis (LAM) - CT and MRI findings with relevance to the urologist. Phukan C, Prabhu S, Venkatramani V. Int Braz J Urol. 2014 Jul-Aug;40(4):574-5. doi: 10.1590/S1677-5538.IBJU.2014.04.19. PubMed PMID: 25251963.
      20: Splenogonadal fusion: pathological features of a rare scrotal mass. Duhli N, Venkatramani V, Panda A, Manojkumar R. Indian J Pathol Microbiol. 2013 Oct-Dec;56(4):474-6. doi: 10.4103/0377-4929.125387. PubMed PMID: 24441256.
      21: Urogenital fistulae in India: results of a retrospective analysis. Venkatramani V, Shanmugasundaram R, Kekre NS. Female Pelvic Med Reconstr Surg. 2014 Jan-Feb;20(1):14-8. doi: 10.1097/SPV.0000000000000040. PubMed PMID: 24368482.
      22: Urethral duplication with unusual cause of bladder outlet obstruction. Venkatramani V, George AJ, Chandrasingh J, Panda A, Devasia A. Indian J Urol. 2016 Apr-Jun;32(2):156-8. doi: 10.4103/0970-1591.174780. PubMed PMID: 27127361; PubMed Central PMCID: PMC4831507.
      23: Emphysematous pyelonephritis in a renal transplant recipient--is it possible to salvage the graft? Vivek V, Panda A, Devasia A. Ann Transplant. 2012; 17:138-41.
      24: Visualization of male reproductive tract during urethrography: sequel of intense backpressure. Venkatramani V, Mukha RP. ANZ J Surg. 2015 May;85(5):393. doi: 10.1111/ans.12461. Epub 2013 Nov 20. PubMed PMID: 24252111.
      25: Equivocal pelvi-ureteric junction obstruction manifesting in a renal transplant recipient. Venkatramani V, Mukha RP, Kekre NS Indian J Urol. 2012 Jul;28(3):350-2. doi: 10.4103/0970-1591.102727. PubMed PMID: 23204671; PubMed Central PMCID: PMC3507412.
      26: Breast gangrene in an HIV-positive patient. Venkatramani V, Pillai S, Marathe S, Rege SA, Hardikar JV. Ann R Coll Surg Engl. 2009 Jul;91(5):W13-4. doi: 10.1308/147870809X401056. PubMed PMID: 19622255; PubMed Central PMCID: PMC2758440.
      27: Can telemedicine reverse the brain drain? Venkatramani V, Roy D. J R Soc Med. 2006 Jan;99(1):5. PubMed PMID: 16388047; PubMed Central PMCID: PMC1325071.
      28: Comparison of glomerular filtration rate (GFR) changes in radical nephrectomy versus nephron sparing surgery (NSS) for pT1 renal cell carcinoma (RCC). Phukan C, Venkatramani V, Banerji JS, Kekre NS, Devasia A. Merit Research Journal of Medicine and Medical Sciences. 2015; 3: published online.
      29: Shock-wave lithotripsy for lower calyceal stones >1cm in size: Out-dated or still standard of care? Kekre NS, Venkatramani V. Med-ej - Journal of TNMGRMU, 2013; published online.
      30: Is Paclitaxel-based chemotherapy the way forward in testicular cancer? Venkatramani V. Indian J Urol 2013; 29:268-9. (Uroscan)
      31: Is it time to rethink maintenance Bacillus Calmette-Guerin? Venkatramani V. Indian J Urol 2012; 28:238-9. (Uroscan)
      32: Audit on the success rate of vesico-vaginal fistulae repairs. Venkatramani V. CMC journal 2013; published online.
      B) Book chapters
      1: Robot-Assisted Radical Cystectomy versus Open Radical Cystectomy. (Chapter 59. Venkatramani V, Parekh DJ. Robotics in Genitourinary Surgery, 2nd ed, edited by Ashok K. Hemal, MD and Mani Menon, MD.
      2: High Intensity Focused Ultrasound (HIFU) Options for High-Risk Prostate Cancer. Nahar B, Venkatramani V and Parekh DJ. Prostate Cancer Clinical Scenarios by Chang and Cookson - Springer International Publishing, in press.
      3: Long term complications of Androgen Deprivation Therapy for Prostate Cancer and how to manage them. Nahar B, Venkatramani V, Barboza MP, Soodana-Prakash N, Punnen S. AUA Update Series 2017, Volume 36, Lession 32: 311-322.

    Speciality Interest
    • Prostate: cancer, BPH Kidney masses Bladder cancer Testicular cancer Adrenal masses Penile cancer Renal transplant